RELAY THERAPEUTICS INC (RLAY) Earnings History & Surprises
NASDAQ:RLAY • US75943R1023
10.69 USD
+0.55 (+5.42%)
At close: Mar 10, 2026
10.69 USD
0 (0%)
After Hours: 3/10/2026, 4:34:19 PM
Past quarterly earnings results for RELAY THERAPEUTICS INC (RLAY), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate-$0.38
Revenue Estimate102K
Last Reported
Release DateFeb 26, 2026
PeriodQ4 / 2025
EPS Reported-$0.32
EPS Surprise 22.41%
Revenue Surprise 38.20%
Beat Rate
69%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.32 | -0.41 | 22.41% | 28.89% | 7M | 5.065M | 38.20% | - |
| Q3 2025 | -0.43 | -0.42 | -1.47% | 31.75% | 186.517K | -100.00% | - | |
| Q2 2025 | -0.41 | -0.50 | 18.23% | 40.58% | 677K | 61.2K | 1,006.21% | - |
| Q1 2025 | -0.46 | -0.50 | 7.59% | 25.81% | 7.679M | 10.2K | 75,184.31% | -23.26% |
| Q4 2024 | -0.45 | -0.57 | 21.46% | 32.84% | 6.202M | -100.00% | - | |
| Q3 2024 | -0.63 | -0.78 | 19.53% | -16.67% | 81.6K | -100.00% | -100.00% | |
| Q2 2024 | -0.69 | -0.75 | 7.69% | 14.81% | 81.6K | -100.00% | -100.00% | |
| Q1 2024 | -0.62 | -0.72 | 13.77% | 20.51% | 10.007M | 79.336K | 12,513.51% | 4,327.88% |
| Q4 2023 | -0.67 | -0.74 | 9.82% | -19.64% | 25.546M | 129.815K | -100.00% | -100.00% |
| Q3 2023 | -0.54 | -0.85 | 36.27% | 28.95% | 25.202M | 375.697K | 6,608.07% | 7,312.35% |
| Q2 2023 | -0.81 | -0.83 | 2.64% | -14.08% | 119K | 706.86K | -83.16% | -67.84% |
| Q1 2023 | -0.78 | -0.71 | -10.62% | -36.84% | 226K | 191.76K | 17.86% | -46.19% |
| Q4 2022 | -0.56 | -0.72 | 21.82% | 9.68% | 250K | 3.366M | -92.57% | -56.14% |
| Q3 2022 | -0.76 | -0.72 | -5.60% | -15.15% | 340K | 1.689M | -79.87% | -49.25% |
| Q2 2022 | -0.71 | -0.64 | -10.74% | 66.19% | 370K | 1.967M | -81.19% | -55.95% |
| Q1 2022 | -0.57 | -0.63 | 9.62% | -21.28% | 420K | 170.003K | 147.05% | -55.79% |
| Q4 2021 | -0.62 | -0.59 | -5.10% | -188.57% | 570K | 3.917M | -85.45% | -99.31% |
| Q3 2021 | -0.66 | -0.65 | -1.33% | -29.41% | 670K | 109.283K | 513.09% | - |
| Q2 2021 | -2.10 | -0.46 | -351.78% | 65.35% | 840K | 6.8M | -87.65% | - |
| Q1 2021 | -0.47 | -0.49 | 4.99% | - | 950K | 4.151M | -77.11% | - |
| Q4 2020 | 0.70 | 0.17 | 307.70% | - | 82.65M | 37.4M | 120.99% | - |
| Q3 2020 | -0.51 | -0.35 | -44.51% | - | - | - | ||
| Q2 2020 | -6.06 | -0.68 | -796.78% | - | - | - | ||
| Q1 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
11.69%
Max EPS beat (4)
22.41%
Min EPS beat (4)
-1.47%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
19,032.20%
Max Revenue beat (4)
75,184.30%
Min Revenue beat (4)
-100.00%
Analysis
In the last 4 quarters, RLAY has beaten EPS estimates in 3 out of 4 releases
RLAY has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, RLAY has beaten the EPS estimates by 11.7% on average.
In the last 4 quarters, RLAY has beaten the revenue estimates by 19032.2% on average.
RELAY THERAPEUTICS INC / RLAY Earnings FAQ
Can you provide the last earnings date for RELAY THERAPEUTICS INC?
RELAY THERAPEUTICS INC (RLAY) last reported earnings on 2/26/2026.
Did RLAY stock beat earnings estimates in the most recent quarter?
RELAY THERAPEUTICS INC (RLAY) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does RLAY stock beat earnings estimates?
In the last 4 quarters, RELAY THERAPEUTICS INC (RLAY) has beaten EPS estimates in 3 out of 4 releases.